AKERO THERAPEUTICS INC (AKRO) Stock Income Statement
USA - NASDAQ:AKRO - US00973Y1082 - Common Stock
54.25 USD
+0.05 (+0.09%)
54.25 USD
0 (0%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 330.02M | 285.42M | 172.87M | 115.16M | 100.89M | |||
| Research and Development | 287.00M | 247.50M | 141.80M | 85.28M | 81.76M | |||
| Selling, General, and Administrative Expenses | 43.02M | 37.93M | 31.07M | 29.87M | 19.13M | |||
| Operating Income | -330.02M | -285.42M | -172.87M | -115.16M | -100.89M | |||
| Interest Income/Expense | 38.75M | 33.36M | 21.11M | -740.00K | 110.00K | |||
| Other Income/Expense | null | null | null | 3.86M | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -292.82M | -252.06M | -151.76M | -112.03M | -100.78M | |||
| Income Tax | null | null | null | 0 | 0 | |||
| Net Income | -292.82M | -252.06M | -151.76M | -112.03M | -100.78M | |||
| EBITDA | null | -285.40M | -172.84M | -115.12M | -100.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.7485 | -3.7544 | -2.8869 | -2.87 | -2.89 | |||
| Non GAAP EPS | null | -3.75 | -2.8499999999999996 | -2.92 | -2.89 | |||
| Statistics | ||||||||
All data in USD